- Sort by Popularity (sales)
- Display 30 Products per page
Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...Published: May 16, 2023 | Price: $5,000.00 – $10,000.00
Your Resource for Business Planning in the Clinical Laboratory Market What's the size of the service market for clinical testing? What type of tests are selling? Where is this market going next five years? Which companies will earn those revenues? Where is growth coming from? How will LDT regulation affect the market? What are companies planning with COVID-19 largely endemic? These questions and more are answered in Kalorama's Clinical Laboratory Services report. laboratories are the workhorse of diagnostic services for the...Published: April 6, 2023 | Price: $3,750.00 – $7,000.00
SKU 23-708: There is a nearly $10 billion-dollar market for hematology and coagulation IVD testing. Increasingly growth is driven by new technologies, the aging population, and the demand for decentralized testing. This report provides: Market sizing for Hematology IVD and Coagulation IVD Markets for Decentralized and Lab-based Segments. Forecasts to 2027 Market Share Country Markets for Hematology (Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Spain, Turkey, United Kingdom, United States) Country Markets for Coagulation (Australia, Brazil, Canada, China,...Published: January 23, 2023 | Price: $5,000.00 – $10,000.00
This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...Published: October 6, 2022 | Price: $5,000.00 – $10,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...Published: June 29, 2022 | Price: $5,000.00 – $10,000.00
This new report from Kalorama Information is designed to provide an overview of the IVD market in India and its influences. The focus is on the IVD discipline including reagents, consumables, calibrators and controls of the following sub-segments: Clinical Chemistry: routine lab testing; substrates, enzymes, homogeneous immunoassays, proteins, ISE (non-POC), HBA1c (non-POC). Includes urinalysis and blood chemistry testing. Immunoassays: hormones and thyroid function, tumor markers, allergy, anemia, neonatal tests, prenatal tests, interleukins, PCT, toxicology and common infectious diseases (HIV, hepatitis,...Published: June 28, 2022 | Price: $6,000.00 – $12,000.00
Clinical Laboratory Services Market, 7th Edition provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland) Asia Pacific (Japan, China, India,...Published: April 19, 2022 | Price: $3,750.00 – $7,500.00
This report, COVID-19 Testing Market Update, 2022, provides market sizing and estimates for COVID-19 tests with some discussion of market impacts of COVID-19. The scourge of COVID-19 continued to occupy laboratories and the in vitro diagnostic (IVD) companies that serve them throughout 2021 and into 2022. Testing already present in large labs and clinics entered the home last year, which added to market revenues. There was 33 BN of revenues in 2021, and the report details the share of antigen,...Published: March 22, 2022 | Price: $7,000.00 – $14,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s IVD Test Procedure Volumes, 2021-2026 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests, and the future potential. In the process, pricing analysis is also performed. This report is an essential resource for the IVD business planner. The...Published: January 6, 2022 | Price: $5,000.00 – $10,000.00
This report, The World Liquid Biopsy Market, 2021, from Kalorama Information, contains up-to-date information and useful data points for business planning: Research vs. Clinical Liquid Biopsy The Market for Liquid Biopsy by Region The Market for Liquid Biopsy Market by Type of Analyte The Market for CTC-based Liquid Biopsy The Market for ctDNA-based Liquid Biopsy The Market for EV and Exosome-based Liquid Biopsy The Market for Multi-Analyte-based Liquid Biopsy The Market for Other Liquid Biopsy Liquid Biopsy Market by Type...Published: November 22, 2021 | Price: $9,000.00 – $12,000.00
Cancer testing is maturing from personalized medicine to precision medicine, where protein and molecular biomarkers are essential for precise diagnosis, therapy selection, therapy monitoring and early detection of cancer recurrence. The World Market for Cancer Diagnostics, as well as relevant industry merger data provided by Kalorama Information, provides authoritative and complete analysis of the cancer testing industry, with expert market sizing and opportunity assessment. Segment markets for cancer testing are comprehensively covered in Kalorama Information’s World Market for Cancer Diagnostics. ...Published: September 29, 2021 | Price: $4,000.00 – $8,000.00
As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...Published: September 29, 2021 | Price: $3,000.00 – $6,000.00
A considerable number of diagnostic tests are available or in development for the detection of autoimmune diseases. Because of this potentially large and growing market, vast opportunity exists for discovery and advancement in this arena. Competition within this market is expected to increase dramatically. However, in fledgling autoimmune IVD diagnostic testing markets, a golden opportunity exists to capitalize on new testing innovations without significant competition. In terms of test options, a substantial amount of overlap exists in the various autoimmune...Published: June 29, 2021 | Price: $4,000.00 – $8,000.00
Latin America (LATAM) is a key target for IVD manufacturers exploring expansion opportunities. This report, The Market for In Vitro Diagnostic Tests in Latin America (Argentina, Brazil, Chile, Colombia, Mexico, Peru, Venezuela and other nations), focuses on the market for reagents and instruments in the most important countries of the continent. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis. The countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador,...Published: June 8, 2021 | Price: $4,000.00 – $8,000.00
Clinical Laboratory Services Market, 6th Edition, new from Kalorama Information, provides an overview of the clinical laboratory industry and the trends driving growth. Included in the report are statistics influencing the industry, incidence of diseases in the U.S. and worldwide demographics, life expectancy, and company strategies. Information is presented as a global focused market report, with key regions discussed including: North America (United States, Canada) Europe, Middle East, and Africa - EMEA (Germany, France, Italy, Spain, United Kingdom, Switzerland) Asia...Published: March 12, 2021 | Price: $3,000.00 – $6,000.00
What is the Size of the IVD Market in 2021? What Impact has COVID-19 Had on IVD Markets? What Major Trends are Affecting the Market in 2021? Diagnostic test products have never been more important. This report, 2021 IVD Market Update and COVID-19 Impact, is an update of the market for in vitro diagnostics products from Kalorama's analysts to reflect the latest information. As part of its coverage, this report contains market sizing for the following categories of IVD: Clinical...Published: July 21, 2020 | Price: $7,500.00 $4,000.00
Published: May 19, 2020 | Price: $5,000.00 – $10,000.00
Kalorama Information’s Hematology and Coagulation Markets (Lab-based and Decentralized Markets) examines the current state of two growing testing markets. Hematology is the study of peripheral blood and bone marrow cells in order to diagnose various diseases of the blood including leukemias, anemia and autoimmune diseases. The menu of hematology tests includes: CBC + 5-part differential (or 3-part differential), manual differential/review, hematocrit, hemoglobin (automated, manual), sedimentation rate, reticulocyte count, white blood cell (WBC) count, platelet count and analysis, and red blood...Published: May 14, 2020 | Price: $4,000.00 – $8,000.00
CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...Published: April 7, 2020 | Price: $750.00 – $1,000.00
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...Published: March 11, 2020 | Price: $4,000.00 – $8,000.00
THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/ This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...Published: January 27, 2020 | Price: $4,750.00 – $9,500.00
Clinical laboratories are an essential part of the health industry. The market for laboratory services ranges from routine blood work to esoteric laboratory-developed tests (LDTs). In addition to diagnosing patients, clinical lab testing may be performed to evaluate disease progression, to monitor drug treatment and conditions, and to determine individual therapy. Kalorama’s Clinical Laboratory Services Market, 5th Edition, examines the world and regional markets and is essential for laboratory and IVD companies seeking to better understand the market potential. The...Published: October 31, 2019 | Price: $3,000.00 – $6,000.00
This report is an update on the worldwide in vitro diagnostics (IVD) market, examining several of the factors that currently contribute to the evolving IVD market picture. The topics discussed are the following: The Worldwide IVD Market, 2019-2024 Market Developments in Selected Markets – North America, EU15/Western Europe, Eastern Europe, Japan and China Genetic Testing New POC Innovations Cancer Testing and Personalized Medicine Hematology Glucose Monitoring Advancements HbA1c Testing New Developments in Infectious Diseases Cytology - Increasing Molecular Dx Options...Published: October 17, 2019 | Price: $5,000.00 – $10,000.00
Given its effectiveness in detecting and monitoring treatment of diabetes, HbA1c has become a high-growth and highly competitive market in IVD testing. Globally, a growing amount of dollars is being spent annually on HbA1c testing, for both professional and self-testing. Over a dozen companies produce analyzers, reagents, workstations, and point-of-care (POC) devices that run HbA1c tests. A major contributing factor to growth is the growing availability of HbA1c testing both at the professional level and at the self-testing level. Kalorama’s...Published: July 23, 2019 | Price: $5,000.00 – $10,000.00
Biomarkers are biological or biochemical molecules, genetic changes, or other characteristics that can be measured; they indicate or predict a condition, risk, or likely biological response. Biomarkers can be used for a range of diagnostic applications including predicting disease risk, diagnosis, predicting prognosis, identifying appropriate therapy for an individual, monitoring disease or for return of a disease, and other applications. The World Market for Biomarkers estimates the world markets for biomarkers and biomarker tests from 2014 to 2024, with 2019...Published: April 30, 2019 | Price: $5,500.00 – $11,000.00
Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Most of the leading industry competitors as well as a sizable number of specialized IVD concerns are active in this product segment. The detection and characterization of infectious diseases hold promising worldwide growth potential as discussed in Kalorama’s Infectious Disease Diagnostics: World Market Analysis: HIV/AIDS, Hepatitis, Tuberculosis, STDs, HAIs, ID/AST, Influenza, TORCH, Other. The World Infectious Disease Testing Market...Published: January 25, 2019 | Price: $5,000.00 – $10,000.00
The maturation of in vitro diagnostic (IVD) markets in developed countries has IVD companies casting their nets in developing countries where rising incomes and standards of living are anticipated to spark a new, health-consciousness population with growing demands for quality medical care. Latin America (LATAM) is a key target for IVD manufacturers. This report, The Market for In Vitro Diagnostic Tests in Latin America, focuses on the market for reagents and instruments in the major countries of the continent. The...Published: October 5, 2018 | Price: $4,500.00 – $9,000.00
The World Market for Veterinary Diagnostics The World Market for Veterinary Diagnostics examines the worldwide veterinary diagnostics market through the performance of its two component markets of companion animal and food animal diagnostics. The report provides analysis of major veterinary disease market s as well as overall market performance and development. Data points provided include: Total Global Animal Diagnostic Testing Market, 2016-2023 (in millions $ at manufacturer level) Global Veterinary Diagnostic Testing Market Share by Region (%) 2018 (US, Europe,...Published: March 30, 2018 | Price: $3,995.00 – $7,990.00
What is The Market for Outsourced Manufacturing of IVD Products? Valued at more than $12 billion in 2017, the global OEM in vitro diagnostic (IVD) manufacturing segment is well positioned for long-term growth. Several trends and factors will boost the revenue potential of this business. Most leading worldwide of producers of proprietary IVD systems will increase their reliance on outside contractors as a cost-effective means to expand product lines, broaden manufacturing capacity and capabilities, and serve selected customers. Contract IVD...Published: September 27, 2017 | Price: $3,600.00 – $7,200.00
The Market for Lab-Developed Test Services and the Market for Instruments and Reagents Sold to Labs This is a unique report with a unique segmentation to help customers find the right segment for their needs. Two separate but related markets are discussed in this report: the market for clinical laboratory services using laboratory developed tests, and the market for products (platforms and consumables) sold to clinical laboratories who uses these products to make LDTs. Both are large and rapidly...